Eton Pharmaceuticals
Manufacturing · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21925 W Field Pkwy Ste 235, Deer Park, I...Phone Number
(847) 787-7361Website
www.etonpharma.comRevenue
$86.9 MillionStock Symbol
ETONIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Eton Pharmaceuticals
Eton Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children, Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis.Explore more
Eton Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Eton Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Eton Pharmaceuticals
Earning: See what the market has to say on Eton Pharmaceuticals recently announced quarterly report
Click to see if Eton Pharmaceuticals had a recent Job posting/layoffs
Check if Eton Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Eton Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Eton Pharmaceuticals launches new products
Check out if Eton Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once Eton Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Eton Pharmaceuticals
Compare insights from companies similar to Eton Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Eton Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Eton Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Eton Pharmaceuticals.
Eton Pharmaceuticals financials insights
Gather financial insights about Eton Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Eton Pharmaceuticals Tech Stack
A closer look at the technologies used by Eton Pharmaceuticals
Most Recent Scoops
Earnings
ended Q2 2026 with $26.8 million in cash after making a $3 million prepayment on outstanding debt, and expects cash generated from operations to grow throughout the second half of the year, prioritizing cash reserves for accretive product acquisitions while accelerating repayment of its remaining credit facility over the next 6 to 12 months.
Acquisitions, Business Finance, Finance, Financial Operations, Financing & Debt
Earnings
Eton Pharmaceuticals has reported general and administrative expenses of $11.6 million for Q2 2026, an increase of 20% compared to $9.7 million in the prior-year period, driven primarily by additional headcount to support business growth, with FDA fees accounting for $0.9 million of the year-over-year increase.
Earnings, Spending/Investment, Finance
Earnings
Eton Pharmaceuticals has raised its full-year 2026 revenue guidance to exceed $145 million, up from its previous guidance of more than $120 million, citing strong second quarter performance and a favorable outlook for the remainder of the year.
Earnings, Forecasting, Finance
Earnings
Eton Pharmaceuticals has reported net income of $11.6 million, or $0.35 per diluted share, for Q2 2026, compared to a net loss of $2.6 million, or $0.10 per basic and diluted share, in the prior-year period, with non-GAAP net income of $14.3 million and diluted EPS of $0.43.
Earnings, Finance
Earnings
Earnings, Finance
Eton Pharmaceuticals News & Media
Why Eton Pharmaceuticals Is Top of the Class Today
Eton's cure for an expensive valuation: a 99% sales growth rate.Eton Pharmaceuticals, Inc. (ETON) Q2 2026 Earnings Call Transcript
Eton Pharmaceuticals, Inc. (ETON) Q2 2026 Earnings Call August 13, 2026 4:30 PM EDTCompany ParticipantsDavid Krempa - Chief Business OfficerSean Brynjelsen...Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results
DEER PARK, Ill., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the quarter ended June 30, 2026.Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
DEER PARK, Ill., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that the Company has licensed U.S. rights to rare disease product candidate ASN-001 (timolol topical gel) from Auson Pharmaceuticals (“Auson”). ASN-001 is under development for the treatment of proliferating superficial infantile hemangiomas.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Eton Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Eton Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children, Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylgl... Read More
